These results highlight the therapeutic potential of DSIP-CBBBP in ameliorating neuronal loss associated with insomnia, suggesting promising avenues for developing treatments for sleep-related neurological impairments
Indirect effects may occur through the medication's profound impact on body weight, adipose tissue distribution, and insulin sensitivity
In June 2024, UBC launched under-the-tongue insulin drops with rapid absorption for diabetes treatment
A 200-pound person losing 20% of body weight (40 pounds) over 12 months at $349 per month pays approximately $105 per pound lost
However, it's important to note that the long-term effects of IF are still not fully understood, and there's some debate about whether IF is superior to continuous caloric restriction, as typically used with semaglutide medication, regarding health and weight loss benefits [4, 7]